Table II. Details of treatment characteristics and clinical outcomes.

5-FU/LV: 5-Fluorouracil/leucovorin; AWD: alive with disease; Bev: bevacizumab; C-ion RT: carbon-ion radiotherapy; PCRT: preoperative chemoradiotherapy; DOD: died of disease; FOLFIRI: 5-fluorouracil/leucovorin and irinotecan; FOLFOX: 5-fluorouracil/leucovorin and oxaliplatin; fr: fractions; HT: hyperthermia; NED: no evidence of disease; RBE: relative biological effectiveness; RT: radiotherapy; SBRT: stereotactic body radiotherapy; SOX: S-1 and oxaliplatin; UFT: tegafur and uracil. *This patient received adjuvant capecitabine and oxaliplatin (XELOX).